Nippon India Pharma Fund IDCW - NAV, Mutual Fund Performance & Portfolio

Home>Mutual Funds>Nippon India Mutual Fund>Nippon India Pharma Fund IDCW

Nippon India Pharma Fund IDCW
Equity
Sectoral / Thematic
Very High Risk
Payout
23.93%
3Y annualised
+0.65% 1D
1M
6M
1Y
3Y
5Y
All
 NAV: 28 Jan 2022₹82.34
Min. SIP amountNA
RatingNA
Fund size₹5,397.29Cr
Understand termsAnnualised returnsAverage of the yearly returns of a mutual fund over a given period.
Absolute returnsThe total return of a mutual fund over a given period.
Returns and rankingsCategory: Equity Sectoral / Thematic
Annualised returns
Absolute returns
1Y3Y5YAll
Fund returns14.3%23.9%16.4%20.9%
Category average58.4%28.2%13.5%NA
Rank with in category351NA
Understand terms
Holdings (23)NameSectorInstrumentAssets
Sun Pharmaceutical Industries Ltd.
HealthcareEquity11.9%
Dr. Reddy's Laboratories Ltd.
HealthcareEquity9.6%
Cipla Ltd.
HealthcareEquity8.8%
Aurobindo Pharma Ltd.
HealthcareEquity7.6%
Lupin Ltd.
HealthcareEquity7.4%
Divi's Laboratories Ltd.
HealthcareEquity6.9%
Torrent Pharmaceuticals Ltd.
HealthcareEquity5.8%
Narayana Hrudayalaya Ltd.
HealthcareEquity5.8%
Apollo Hospitals Enterprise Ltd.
HealthcareEquity5.3%
Abbott India Ltd.
HealthcareEquity4.7%
See All
Understand termsExpense ratioA fee payable to a mutual fund house for managing your mutual fund investments. It is the total percentage of a company’s fund assets used for administrative, management, advertising, and other expenses.
TaxA percentage of your capital gains payable to the government upon exiting your mutual fund investments. Taxation is categorized as long-term capital gains (LTCG) and short-term capital gains (STCG) depending on your holding period and the type of fund.
Exit loadA fee payable to a mutual fund house for exiting a fund (fully or partially) before the completion of a specified period from the date of investment.
Stamp dutyA form of tax payable for the purchase or sale of an asset or security. 
Past expense ratio & exit load
Expense ratio
Exit load
31 Dec 2021 - Present
1.95%
30 Nov 2021 - 31 Dec 2021
2.00%
31 Oct 2021 - 30 Nov 2021
1.89%
30 Sep 2021 - 31 Oct 2021
1.88%
31 Aug 2021 - 30 Sep 2021
1.95%
31 Jul 2021 - 31 Aug 2021
1.98%
30 Jun 2021 - 31 Jul 2021
2.00%
31 May 2021 - 30 Jun 2021
1.95%
30 Apr 2021 - 31 May 2021
2.04%
31 Mar 2021 - 30 Apr 2021
1.83%
28 Feb 2021 - 31 Mar 2021
1.97%
31 Jan 2021 - 28 Feb 2021
1.99%
31 Dec 2020 - 31 Jan 2021
2.02%
30 Nov 2020 - 31 Dec 2020
2.05%
31 Oct 2020 - 30 Nov 2020
2.03%
30 Sep 2020 - 31 Oct 2020
2.00%
31 Aug 2020 - 30 Sep 2020
2.09%
31 Jul 2020 - 31 Aug 2020
2.15%
30 Jun 2020 - 31 Jul 2020
2.07%
31 May 2020 - 30 Jun 2020
2.24%
30 Apr 2020 - 31 May 2020
2.13%
31 Mar 2020 - 30 Apr 2020
2.32%
29 Feb 2020 - 31 Mar 2020
2.10%
31 Jan 2020 - 29 Feb 2020
2.15%
31 Dec 2019 - 31 Jan 2020
2.07%
30 Nov 2019 - 31 Dec 2019
2.13%
31 Oct 2019 - 30 Nov 2019
2.20%
30 Sep 2019 - 31 Oct 2019
2.06%
31 Aug 2019 - 30 Sep 2019
2.17%
31 Jul 2019 - 31 Aug 2019
2.08%
30 Jun 2019 - 31 Jul 2019
2.05%
31 May 2019 - 30 Jun 2019
2.14%
30 Apr 2019 - 31 May 2019
2.21%
31 Mar 2019 - 30 Apr 2019
2.10%
28 Feb 2019 - 31 Mar 2019
2.16%
31 Jan 2019 - 28 Feb 2019
2.25%
31 Dec 2018 - 31 Jan 2019
2.09%
30 Nov 2018 - 31 Dec 2018
2.35%
31 Oct 2018 - 30 Nov 2018
2.30%
30 Sep 2018 - 31 Oct 2018
2.42%
31 Aug 2018 - 30 Sep 2018
2.42%
31 Jul 2018 - 31 Aug 2018
2.47%
30 Jun 2018 - 31 Jul 2018
2.48%
31 May 2018 - 30 Jun 2018
2.10%
30 Apr 2018 - 31 May 2018
2.10%
31 Mar 2018 - 30 Apr 2018
2.11%
28 Feb 2018 - 31 Mar 2018
2.10%
31 Jan 2018 - 28 Feb 2018
2.10%
31 Dec 2017 - 31 Jan 2018
2.11%
30 Nov 2017 - 31 Dec 2017
2.12%
31 Oct 2017 - 30 Nov 2017
2.13%
Expense ratio, exit load and taxExpense ratio: 1.95%Inclusive of GST
Exit loadExit load of 1% if redeemed within 1 month.
Stamp duty0.005% (from July 1st, 2020)
Tax implicationReturns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year. 
Understand terms
Check past data
Minimum investment amountsMin. for 1st investmentNA
Min. for 2nd investment onwardsNA
Min. for SIPNA
Fund managementSailesh Raj Bhan
Mar 2005 - Present
View details
Education
Mr. Bhan is an MBA (Finance) and CFA.
Experience
Prior to joining Nippon India Mutual Fund, he has worked with Emkay Share & Stock Broker Pvt. Ltd, Shah & Sequeira Invst. Pvt. Ltd, ICFAI- Securities Research Center Analyst - Equity Research.
Also manages these schemes
Nippon India Multi Cap Fund Growth
Nippon India Multi Cap Fund Bonus
Nippon India Multi Cap Fund IDCW
Nippon India Pharma Fund Growth
Nippon India Pharma Fund Bonus
Nippon India Pharma Fund IDCW
Nippon India Consumption Fund Growth
Nippon India Consumption Fund Bonus
Nippon India Consumption Fund IDCW
Nippon India Large Cap Fund Growth
Nippon India Large Cap Fund IDCW
Nippon India Large Cap Fund Bonus
Nippon India Large Cap Fund Direct Growth
Nippon India Large Cap Fund Direct Bonus
Nippon India Large Cap Fund Direct IDCW
Nippon India Multi Cap Fund Direct Growth
Nippon India Multi Cap Fund Direct Bonus
Nippon India Multi Cap Fund Direct IDCW
Nippon India Consumption Fund Direct Bonus
Nippon India Consumption Fund Direct Growth
Nippon India Consumption Fund Direct IDCW
Nippon India Pharma Fund Direct IDCW
Nippon India Pharma Fund Direct Bonus
Nippon India Pharma Fund Direct Growth
Reliance Close Ended Equity Fund Series A Growth
Reliance Close Ended Equity Fund Series A Direct Growth
Reliance Close Ended Equity Fund Series A IDCW
Reliance Close Ended Equity Fund Series B Growth
Reliance Close Ended Equity Fund Series B Direct Growth
Reliance Close Ended Equity Fund Series B IDCW
Reliance Close Ended Equity Fund II Series A Direct Growth
Reliance Close Ended Equity Fund II Series A IDCW
Reliance Close Ended Equity Fund II Series A Growth
Nippon India India Opportunities Fund Series A Regular Growth
Nippon India India Opportunities Fund Series A Direct Growth
Nippon India India Opportunities Fund Series A Regular IDCW
Nippon India India Opportunities Fund Series A Direct IDCW
Fund house & investment objective
Nippon India Mutual Fund
Rank (total assets)NA
Total AUMNA
Date of IncorporationNA
 Nippon India Pharma Fund IDCW is a Equity Mutual Fund Scheme launched by NA. This scheme was made available to investors on 29 Jan 2022. S
 Nippon India Pharma Fund IDCW is a Equity Mutual Fund Scheme launched by NA. This scheme was made available to investors on 29 Jan 2022. Sailesh Raj Bhan is the Current Fund Manager of Nippon India Pharma Fund IDCW fund. The fund currently has an Asset Under Management(AUM) of NA Cr and the Latest NAV as of 28 Jan 2022 is ₹82.34.
The Nippon India Pharma Fund IDCW is rated Very High risk. Minimum SIP Investment is set to 100. Exit load of 1% if redeemed within 1 month.
...Read more
Investment Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated comp
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
...Read more
Fund benchmarkS&P BSE Healthcare TRI
Scheme Information Document(SID)
Fund house contact details
Address
NA
Phone
NA
Launch Date
NA
E-mail
NA
Website
NA
Nippon India Mutual Fund
Asset Management Company
Custodian
Deutsche Bank
Registrar & Transfer Agent
KFin Tech
Address
Karvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,
Email
[email protected]
Website
www.karvymfs.com
Compare funds
Nippon India Pharma Fund IDCW
VS
Add mutual fund to compare
FAQsHow to Invest in Nippon India Pharma Fund IDCW
You can easily invest in Nippon India Pharma Fund IDCW in a hassle-free manner on Groww. The process is extremely simple, quick and completely paperless. Invest in a few minutes with the following steps: Log on to your Groww account
 Search for Nippon India Pharma Fund IDCW from the search box 
 In order to invest, you will have to complete all the KYC formalities which are completely online and paperless and take a few minutes to complete
 Once you are done with that, you can start investing in Nippon India Pharma Fund IDCW as SIP or lumpsum as per your investment objective and risk tolerance
What kind of returns does Nippon India Pharma Fund IDCW provide?
The Nippon India Pharma Fund IDCW has been there from 05 Jun 2004 and the average annual returns provided by this
fund is 14.31% since its inception.
How much expense ratio is charged by Nippon India Pharma Fund IDCW?
The term Expense Ratio used for Nippon India Pharma Fund IDCW or any other mutual fund is the annual charges one needs to pay to the Mutual Fund company for managing your investments in that fund. 

The Expense Ratio of Nippon India Pharma Fund IDCW is 1.95% as of 29 Jan 2022...
What is the AUM of Nippon India Pharma Fund IDCW?
The AUM, short for Assets Under Management of Nippon India Pharma Fund IDCW is ₹5,397.29Cr as of 29 Jan 2022.
How to Redeem Nippon India Pharma Fund IDCW?
If you want to sell your Nippon India Pharma Fund IDCW holdings, go to your holding on the app or
web and simply click on it. You will get two options - redeem & invest more; click on redeem and enter your
desired amount or if you wish to redeem the entire holding amount then select the 'redeem all' checkbox.
Can I invest in SIP and Lump Sum of Nippon India Pharma Fund IDCW?
You can select either SIP  or Lumpsum  investment of Nippon India Pharma Fund IDCW based on your investment objective and risk tolerance.
What is the NAV of Nippon India Pharma Fund IDCW?
The NAV of Nippon India Pharma Fund IDCW is ₹82.34 as of 28 Jan 2022.
What is the PE and PB ratio of Nippon India Pharma Fund IDCW?
The PE ratio ratio of Nippon India Pharma Fund IDCW is determined by dividing the market price by its earnings per share and the PB ratio of the same is evaluated by dividing the stock price per share by its book value per share (BVPS).

	1Y	3Y	5Y	All
Fund returns	14.3%	23.9%	16.4%	20.9%
Category average	58.4%	28.2%	13.5%	NA
Rank with in category	3	5	1	NA

Name	Sector	Instrument	Assets
Sun Pharmaceutical Industries Ltd.	Healthcare	Equity	11.9%
Dr. Reddy's Laboratories Ltd.	Healthcare	Equity	9.6%
Cipla Ltd.	Healthcare	Equity	8.8%
Aurobindo Pharma Ltd.	Healthcare	Equity	7.6%
Lupin Ltd.	Healthcare	Equity	7.4%
Divi's Laboratories Ltd.	Healthcare	Equity	6.9%
Torrent Pharmaceuticals Ltd.	Healthcare	Equity	5.8%
Narayana Hrudayalaya Ltd.	Healthcare	Equity	5.8%
Apollo Hospitals Enterprise Ltd.	Healthcare	Equity	5.3%
Abbott India Ltd.	Healthcare	Equity	4.7%

Rank (total assets)	NA
Total AUM	NA

Date of Incorporation	NA

Fund benchmark	S&P BSE Healthcare TRI

No.11, 2nd floor, 80 FT Road
4th Block, S.T Bed, Koramangala
Bengaluru – 560034
Contact Us
PRODUCTS
StocksFutures & OptionsMutual FundsFixed DepositUS Stocks
GROWW
About UsPricingBlogMedia & PressCareersHelp and Support
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestGroww AcademySitemap
ⓒ 2016-2022 Groww. All rights reserved, Built with ♥in India

Rating	NA
Fund size	₹5,397.29Cr